creatine has been researched along with Weight Loss in 17 studies
Weight Loss: Decrease in existing BODY WEIGHT.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Multiple pilot studies, including one in colorectal cancer patients, suggest that creatine, an amino acid derivative, augments muscle, improves strength, and thereby could palliate the cancer anorexia/weight loss syndrome." | 9.24 | A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial. ( Adonizio, CS; Atherton, PJ; Jaslowski, AJ; Jatoi, A; Le-Lindqwister, NA; Loprinzi, C; Moore, DF; Rowland, KM; Sloan, J; Steen, PD, 2017) |
| "Multiple pilot studies, including one in colorectal cancer patients, suggest that creatine, an amino acid derivative, augments muscle, improves strength, and thereby could palliate the cancer anorexia/weight loss syndrome." | 5.24 | A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial. ( Adonizio, CS; Atherton, PJ; Jaslowski, AJ; Jatoi, A; Le-Lindqwister, NA; Loprinzi, C; Moore, DF; Rowland, KM; Sloan, J; Steen, PD, 2017) |
| "Weight loss is a common symptom of Parkinson's disease and is associated with impaired quality of life." | 2.84 | Predictors of weight loss in early treated Parkinson's disease from the NET-PD LS-1 cohort. ( Boyd, J; Li, R; Pérez, A; Ren, X; Wills, AM, 2017) |
| "Weight loss was 7." | 2.71 | Effect of an energy-restricted, high-protein, low-fat diet relative to a conventional high-carbohydrate, low-fat diet on weight loss, body composition, nutritional status, and markers of cardiovascular health in obese women. ( Clifton, PM; Foster, PR; Keogh, JB; Noakes, M, 2005) |
| "Obesity is associated with adverse effects on brain health, including an increased risk of neurodegenerative diseases." | 1.91 | Change in medial frontal cerebral metabolite concentrations following bariatric surgery. ( Bottari, SA; Britton, MK; Chen, A; Cohen, RA; Friedman, J; Gunstad, J; Porges, EC; Williamson, JB; Woods, AJ, 2023) |
| "Brain edema was maximal on MR imaging 3 h after poisoning." | 1.42 | Early brain magnetic resonance imaging can predict short and long-term outcomes after organophosphate poisoning in a rat model. ( Cohen, Y; Eisenkraft, A; Kadar, T; Kassirer, M; Milk, N; Rosman, Y; Shiyovich, A; Shrot, S; Tauber, M, 2015) |
| "We report a case with morbid obesity whose renal function was stabilized with aggressive management of his obesity." | 1.33 | Does treating obesity stabilize chronic kidney disease? ( Agnani, S; Atray, NK; Gupta, R; Vachharajani, TJ; Vachharajani, VT, 2005) |
| "Pulegone was given orally by gavage to groups of 28 SPF Wistar rats at dosage levels of 0 or 160 mg/kg body weight per day for 28 days." | 1.30 | Lack of histological cerebellar changes in Wistar rats given pulegone for 28 days. Comparison of immersion and perfusion tissue fixation. ( Mølck, AM; Olsen, P; Poulsen, M; Tindgard Lauridsen, S, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.88) | 18.7374 |
| 1990's | 3 (17.65) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 6 (35.29) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Bottari, SA | 1 |
| Cohen, RA | 1 |
| Friedman, J | 1 |
| Porges, EC | 1 |
| Chen, A | 1 |
| Britton, MK | 1 |
| Gunstad, J | 1 |
| Woods, AJ | 1 |
| Williamson, JB | 1 |
| Schilling, E | 1 |
| Böhmer, F | 1 |
| Fritzsche, C | 1 |
| Jatoi, A | 1 |
| Steen, PD | 1 |
| Atherton, PJ | 1 |
| Moore, DF | 1 |
| Rowland, KM | 1 |
| Le-Lindqwister, NA | 1 |
| Adonizio, CS | 1 |
| Jaslowski, AJ | 1 |
| Sloan, J | 1 |
| Loprinzi, C | 1 |
| Wills, AM | 1 |
| Li, R | 1 |
| Pérez, A | 1 |
| Ren, X | 1 |
| Boyd, J | 1 |
| Genc, G | 1 |
| Okuyucu, A | 1 |
| Meydan, BC | 1 |
| Yavuz, O | 1 |
| Nisbet, O | 1 |
| Hokelek, M | 1 |
| Bedir, A | 1 |
| Ozkaya, O | 1 |
| Gungunes, A | 1 |
| Ozbek, M | 1 |
| Ginis, Z | 1 |
| Sahin, M | 1 |
| Demirci, T | 1 |
| Cakir Ozkaya, E | 1 |
| Karbek, B | 1 |
| Sayki Arslan, M | 1 |
| Ozturk Unsal, I | 1 |
| Tutal Akkaya, E | 1 |
| Ucan, B | 1 |
| Gultuna Ozguclu, S | 1 |
| Cakal, E | 1 |
| Topaloglu, O | 1 |
| Delibasi, T | 1 |
| Shrot, S | 1 |
| Tauber, M | 1 |
| Shiyovich, A | 1 |
| Milk, N | 1 |
| Rosman, Y | 1 |
| Eisenkraft, A | 1 |
| Kadar, T | 1 |
| Kassirer, M | 1 |
| Cohen, Y | 1 |
| Deldicque, L | 1 |
| Francaux, M | 1 |
| HUNTER, J | 1 |
| RAULSTON, WR | 1 |
| Noakes, M | 1 |
| Keogh, JB | 1 |
| Foster, PR | 1 |
| Clifton, PM | 1 |
| Agnani, S | 1 |
| Vachharajani, VT | 1 |
| Gupta, R | 1 |
| Atray, NK | 1 |
| Vachharajani, TJ | 1 |
| Santos, RV | 1 |
| Batista, ML | 1 |
| Caperuto, EC | 1 |
| Costa Rosa, LF | 1 |
| Iwao, S | 1 |
| Mori, K | 1 |
| Sato, Y | 1 |
| Mølck, AM | 1 |
| Poulsen, M | 1 |
| Tindgard Lauridsen, S | 1 |
| Olsen, P | 1 |
| Oöpik, V | 2 |
| Pääsuke, M | 2 |
| Timpmann, S | 2 |
| Medijainen, L | 2 |
| Ereline, J | 2 |
| Smirnova, T | 1 |
| Rockwell, JA | 1 |
| Rankin, JW | 1 |
| Toderico, B | 1 |
| Gapejeva, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Multicenter, Double-Blind, Parallel Group, Placebo Controlled Study of Creatine in Subjects With Treated Parkinson's Disease (PD) Long Term Study (LS-1)[NCT00449865] | Phase 3 | 1,741 participants (Actual) | Interventional | 2007-03-31 | Terminated (stopped due to Futility) | ||
| Food Allergen Eliminations and Combined Protocols for Obesity Reduction: a Preliminary Comparison Study[NCT03821818] | 20 participants (Anticipated) | Observational | 2018-03-05 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
All outcomes were coded such that higher scores indicated worse outcomes. Patients were ranked on each outcome and their ranks were summed (summed-ranks). Higher summed ranks (range, 5-4775) indicate worse outcomes. The mean summed ranks were compared by treatment group by a global statistical test (GST). (NCT00449865)
Timeframe: Change from baseline to 5 YEARS
| Intervention | summed-ranks (Mean) |
|---|---|
| Placebo | 2360 |
| Creatine | 2414 |
1 review available for creatine and Weight Loss
| Article | Year |
|---|---|
Potential harmful effects of dietary supplements in sports medicine.
Topics: Alkaloids; Amines; Creatine; Dietary Supplements; Drug Contamination; Drug Interactions; Drug Overdo | 2016 |
7 trials available for creatine and Weight Loss
| Article | Year |
|---|---|
A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial.
Topics: Aged; Anorexia; Creatine; Double-Blind Method; Female; Humans; Male; Middle Aged; Neoplasms; Placebo | 2017 |
Predictors of weight loss in early treated Parkinson's disease from the NET-PD LS-1 cohort.
Topics: Age Factors; Antiparkinson Agents; Creatine; Disease Progression; Dopamine Agents; Double-Blind Meth | 2017 |
Effect of an energy-restricted, high-protein, low-fat diet relative to a conventional high-carbohydrate, low-fat diet on weight loss, body composition, nutritional status, and markers of cardiovascular health in obese women.
Topics: Adipose Tissue; Adult; Biomarkers; Body Composition; Bone and Bones; Cardiovascular Diseases; Choles | 2005 |
Effects of meal frequency on body composition during weight control in boxers.
Topics: Adult; Body Composition; Body Mass Index; Body Weight; Boxing; Creatine; Diet, Reducing; Energy Meta | 1996 |
Effect of creatine supplementation during rapid body mass reduction on metabolism and isokinetic muscle performance capacity.
Topics: Adult; Ammonia; Biomechanical Phenomena; Creatine; Dietary Supplements; Glucose; Glycogen; Humans; L | 1998 |
Creatine supplementation affects muscle creatine during energy restriction.
Topics: Adipose Tissue; Adolescent; Adult; Body Composition; Creatine; Humans; Male; Muscle, Skeletal; Nitro | 2001 |
Effects of creatine supplementation during recovery from rapid body mass reduction on metabolism and muscle performance capacity in well-trained wrestlers.
Topics: Adult; Ammonia; Blood Glucose; Body Weight; Creatine; Cross-Over Studies; Dietary Supplements; Doubl | 2002 |
9 other studies available for creatine and Weight Loss
| Article | Year |
|---|---|
Change in medial frontal cerebral metabolite concentrations following bariatric surgery.
Topics: Bariatric Surgery; Choline; Creatine; Humans; Inositol; Obesity; Proton Magnetic Resonance Spectrosc | 2023 |
[20-year-old man with adynamia and syncopes].
Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; Animals; Creatine; Diagnosis, Differential; Huma | 2020 |
Effect of free creatine therapy on cisplatin-induced renal damage.
Topics: Animals; Antineoplastic Agents; Cisplatin; Creatine; DNA Damage; Drug Evaluation, Preclinical; Kidne | 2014 |
Serum nesfatin-1 levels in overt and subclinical hyperthyroidism.
Topics: Adult; Appetite; Blood Glucose; Body Mass Index; Body Weight; Calcium-Binding Proteins; Creatine; DN | 2014 |
Early brain magnetic resonance imaging can predict short and long-term outcomes after organophosphate poisoning in a rat model.
Topics: Animals; Aspartic Acid; Atropine; Behavior, Animal; Brain; Brain Edema; Choline; Cholinesterase Reac | 2015 |
Creatine concentration and weight loss in denervated skeletal muscle.
Topics: Creatine; Muscle, Skeletal; Muscles; Weight Loss | 1946 |
Does treating obesity stabilize chronic kidney disease?
Topics: Adult; Bariatric Surgery; Creatine; Gastric Bypass; Humans; Kidney; Kidney Failure, Chronic; Male; O | 2005 |
Chronic supplementation of creatine and vitamins C and E increases survival and improves biochemical parameters after Doxorubicin treatment in rats.
Topics: Alanine Transaminase; Animals; Antibiotics, Antineoplastic; Ascorbic Acid; Creatine; Creatinine; Dox | 2007 |
Lack of histological cerebellar changes in Wistar rats given pulegone for 28 days. Comparison of immersion and perfusion tissue fixation.
Topics: Animals; Cerebellum; Creatine; Cyclohexane Monoterpenes; Dose-Response Relationship, Drug; Female; L | 1998 |